201 related articles for article (PubMed ID: 3026133)
41. Immunocytochemistry of pituitary tumors.
Heitz PU; Landolt AM; Zenklusen HR; Kasper M; Reubi JC; Oberholzer M; Roth J
J Histochem Cytochem; 1987 Sep; 35(9):1005-11. PubMed ID: 2440942
[TBL] [Abstract][Full Text] [Related]
42. Argyrophil granules in the human pituitary.
Urbanski SJ; Kovacs K; McComb DJ; Ryan N
Acta Histochem; 1982; 70(1):69-77. PubMed ID: 6179126
[TBL] [Abstract][Full Text] [Related]
43. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
44. Immunocytochemical study of S-100 protein in human pituitary adenomas.
Turpin G; Heshmati HM; Kujas M; Grémain J; Jacque CM; Racadot J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(2):107-9. PubMed ID: 2901158
[TBL] [Abstract][Full Text] [Related]
45. CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation.
Xu Y; Wang Y; Ma G; Wang Q; Wei G
J Neurooncol; 2014 Feb; 116(3):625-32. PubMed ID: 24420924
[TBL] [Abstract][Full Text] [Related]
46. Prolactin cell adenomas of the human pituitary. Morphologic features of prolactin cells in the nontumorous portions of the anterior lobe.
Kovacs K; Ryan N; Horvath E; Ezrin C; Penz G
Horm Metab Res; 1978 Sep; 10(5):409-12. PubMed ID: 711135
[TBL] [Abstract][Full Text] [Related]
47. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors.
Japón MA; Urbano AG; Sáez C; Segura DI; Cerro AL; Diéguez C; Alvarez CV
J Clin Endocrinol Metab; 2002 Apr; 87(4):1879-84. PubMed ID: 11932334
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical studies of chromogranins (A and C) in pituitary adenomas.
Oda K; Inada K; Osamura RY
Pathol Res Pract; 1991 Jun; 187(5):626-8. PubMed ID: 1717962
[TBL] [Abstract][Full Text] [Related]
49. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
Yamada S; Aiba T; Sano T; Kovacs K; Shishiba Y; Sawano S; Takada K
Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
[TBL] [Abstract][Full Text] [Related]
50. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
[TBL] [Abstract][Full Text] [Related]
51. Co-localization of human growth hormone and human prolactin in hormonally pure human growth hormone-producing pituitary adenomas.
Kurosaki M; Watanabe T; Hori T; Hirai K; Kawakami H; Hirano H
Neurol Med Chir (Tokyo); 1998 Jun; 38(6):335-9; discussion 340-1. PubMed ID: 9689816
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical study of cells positive for glial fibrillary acidic protein (GFAP) in the human pituitary gland, with special reference to folliculo-stellate cells.
Redecker P; Fechner J
Histochemistry; 1989; 91(3):227-34. PubMed ID: 2722564
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical expression of SNAP-25 protein in adenomas of the human pituitary.
Rotondo F; Kovacs K; Scheithauer BW; Horvath E; Bell CD; Lloyd RV; Cusimano M
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):477-81. PubMed ID: 18633321
[TBL] [Abstract][Full Text] [Related]
54. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
[TBL] [Abstract][Full Text] [Related]
55. Identification of CD133+ cells in pituitary adenomas.
Yunoue S; Arita K; Kawano H; Uchida H; Tokimura H; Hirano H
Neuroendocrinology; 2011; 94(4):302-12. PubMed ID: 21912092
[TBL] [Abstract][Full Text] [Related]
56. Difference of lectin binding sites of secretory granules between normal pituitary and adenoma cells.
Hori T; Nishiyama F; Anno Y; Adachi S; Numata H; Hokama Y; Muraoka K; Hirano H
Acta Neuropathol; 1985; 66(3):177-83. PubMed ID: 2990144
[TBL] [Abstract][Full Text] [Related]
57. Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas.
Giorgi RR; Correa-Giannella ML; Casarini AP; Machado MC; Bronstein MD; Cescato VA; Giannella-Neto D
Neuroendocrinology; 2005; 82(3-4):208-14. PubMed ID: 16601360
[TBL] [Abstract][Full Text] [Related]
58. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
[TBL] [Abstract][Full Text] [Related]
59. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
Felix IA; Horvath E; Kovacs K; Smyth HS; Killinger DW; Vale J
Acta Neuropathol; 1986; 71(1-2):76-82. PubMed ID: 3776476
[TBL] [Abstract][Full Text] [Related]
60. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
